Butterfly Network to Participate at the Virtual BTIG Digital Health Forum on November 25, 2024
Butterfly Network (NYSE: BFLY) has announced its participation in the upcoming virtual BTIG Digital Health Forum on November 25, 2024. The company's leadership will engage in two key presentations: a 9:00 AM ET Fireside Chat featuring CEO Joseph DeVivo and CFO Heather Getz discussing Butterfly's technology and strategy, and a 3:00 PM ET Panel Discussion where CMO Dr. John Martin will explore the impact of tools like Butterfly iQ3 on diagnostic and treatment approaches. One-on-one meetings with executives can be arranged through BTIG representatives.
Butterfly Network (NYSE: BFLY) ha annunciato la sua partecipazione al prossimo BTIG Digital Health Forum virtuale che si terrà il 25 novembre 2024. La leadership dell'azienda parteciperà a due presentazioni chiave: una Conversazione al Focolare delle 9:00 AM ET con il CEO Joseph DeVivo e il CFO Heather Getz, che discuteranno la tecnologia e la strategia di Butterfly, e una Discussione Panel delle 3:00 PM ET in cui il CMO Dr. John Martin esaminerà l'impatto di strumenti come Butterfly iQ3 sugli approcci diagnostici e terapeutici. Gli incontri one-on-one con i dirigenti possono essere organizzati tramite i rappresentanti di BTIG.
Butterfly Network (NYSE: BFLY) ha anunciado su participación en el próximo foro virtual de salud digital BTIG que se llevará a cabo el 25 de noviembre de 2024. El equipo directivo de la empresa participará en dos presentaciones clave: una charla informal a las 9:00 AM ET con el CEO Joseph DeVivo y la CFO Heather Getz, donde discutirán la tecnología y la estrategia de Butterfly, y una mesa redonda a las 3:00 PM ET donde el CMO Dr. John Martin explorará el impacto de herramientas como Butterfly iQ3 en los enfoques de diagnóstico y tratamiento. Se pueden organizar reuniones uno a uno con ejecutivos a través de los representantes de BTIG.
버터플라이 네트워크 (NYSE: BFLY)는 2024년 11월 25일에 열리는 가상 BTIG 디지털 헬스 포럼에 참가한다고 발표했습니다. 회사의 리더십은 두 가지 주요 발표에 참여할 예정입니다: 동부 표준시 오전 9시 의자 간담회에서 CEO 조셉 드비보와 CFO 헤더 겟츠가 버터플라이의 기술과 전략에 대해 논의하고, 동부 표준시 오후 3시 패널 토론에서는 CMO인 존 마틴 박사가 버터플라이 iQ3와 같은 도구가 진단 및 치료 접근 방식에 미치는 영향을 탐구할 것입니다. BTIG 대표를 통해 경영진과의 1:1 미팅을 조정할 수 있습니다.
Butterfly Network (NYSE: BFLY) a annoncé sa participation au prochain forum virtuel de santé numérique BTIG qui se tiendra le 25 novembre 2024. La direction de l'entreprise participera à deux présentations clés : un entretien au coin du feu à 9h00 ET avec le PDG Joseph DeVivo et la CFO Heather Getz, qui discuteront de la technologie et de la stratégie de Butterfly, et une table ronde à 15h00 ET où le CMO Dr. John Martin explorera l'impact d'outils comme Butterfly iQ3 sur les approches de diagnostic et de traitement. Des réunions individuelles avec les dirigeants peuvent être organisées via des représentants de BTIG.
Butterfly Network (NYSE: BFLY) hat seine Teilnahme am kommenden virtuellen BTIG Digital Health Forum am 25. November 2024 angekündigt. Die Unternehmensführung wird an zwei zentralen Präsentationen teilnehmen: einem Fireside Chat um 9:00 Uhr ET, bei dem CEO Joseph DeVivo und CFO Heather Getz über die Technologie und Strategie von Butterfly sprechen, sowie einer Podiumsdiskussion um 15:00 Uhr ET, in der CMO Dr. John Martin die Auswirkungen von Werkzeugen wie Butterfly iQ3 auf diagnostische und therapeutische Ansätze untersuchen wird. Einzelgespräche mit Führungskräften können über BTIG-Vertreter arrangiert werden.
- None.
- None.
Presentations at the event will include:
- 9:00 am ET Fireside Chat: Joseph DeVivo, President, Chief Executive Officer and Chairman, and Heather Getz, Executive Vice President, Chief Financial and Operations Officer, will discuss Butterfly’s differentiated technology, strategic approach, and future opportunities.
- 3:00 pm ET Panel Discussion: John Martin, MD, Chief Medical Officer, will discuss the role of novel tools, like Butterfly iQ3, in improving the diagnostic and treatment paradigm.
To schedule a one-on-one meeting with Mr. DeVivo and Ms. Getz, please reach out to your BTIG representative.
About Butterfly Network
Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network is a digital health company with a mission to democratize medical imaging by making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound. Butterfly created the world's first handheld single-probe, whole-body ultrasound system using semiconductor technology, Butterfly iQ. The company has continued to innovate, leveraging the benefits of Moore’s Law, to launch its second-generation Butterfly iQ+ in 2020, and third generation iQ3 in 2024 – each with increased processing power and performance enhancements. The disruptive technology has been recognized by TIME’s Best Inventions, Fast Company’s World Changing Ideas, CNBC Disruptor 50, and MedTech Breakthrough Awards, among other accolades. With its proprietary Ultrasound-on-Chip™ technology, intelligent software, and educational offerings, Butterfly is paving the way to mass adoption of ultrasound for earlier detection and remote management of health conditions around the world. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of
View source version on businesswire.com: https://www.businesswire.com/news/home/20241111947043/en/
Butterfly Investors:
Heather Getz
Chief Financial and Operations Officers, Butterfly
investors@butterflynetwork.com
Source: Butterfly Network, Inc.
FAQ
When is Butterfly Network (BFLY) presenting at the BTIG Digital Health Forum 2024?
Who are the Butterfly Network (BFLY) executives speaking at the BTIG Digital Health Forum?
What topics will Butterfly Network (BFLY) discuss at the BTIG Digital Health Forum 2024?
How can investors arrange meetings with Butterfly Network (BFLY) management at the BTIG forum?
